Transcode Therapeutics Stock Forecast

Sell candidate since Jul 24, 2026 Loss -23.10%

The TransCode Therapeutics, Inc. stock price fell by -13.14% on the last day (Friday, 31st Jul 2026) from $5.25 to $4.56. During the last trading day the stock fluctuated 20.13% from a day low at $4.47 to a day high of $5.37. The price has fallen in 8 of the last 10 days and is down by -45.91% for this period. Volume has increased on the last day by 20 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 30 thousand shares were bought and sold for approximately $135.39 thousand.

The stock has broken the very wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $4.81. A reaction back to this level may hold a second chance to get out before further falls.

RNAZ Signals & Forecast

There are few to no technical positive signals at the moment. The TransCode Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.49 and $6.65. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -52.48%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). TransCode Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for TransCode Therapeutics, Inc. stock

TransCode Therapeutics, Inc. finds support from accumulated volume at $4.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.90 between high and low, or 20.13%. For the last week, the stock has had daily average volatility of 12.94%.

TransCode Therapeutics, Inc. is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RNAZ) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect TransCode Therapeutics, Inc. to open at $4.80, and during the day (based on 14 day Average True Range), to move between $4.12 and $5.00, which gives a possible trading interval of +/-$0.87 (+/-21.15%) up or down from last closing price. If TransCode Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 21.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.55 (0.22%) than the resistance at $5.04 (10.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is TransCode Therapeutics, Inc. stock A Buy?

The TransCode Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe TransCode Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.594 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $4.80 ( 5.26%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk